• sarila
• dr.pharmendra Ahuja
• Shilpa Thakur
• Anamika Verma
• Anshul Saini

abstract.In this review, we discuss a recently approved drug for asthma management. There are lots of publications on asthma that identify the treatment of asthma but some researchers doubt their work. this paper includes the introduction of an asthma study and a combo of two new medications for asthma. &Classification of asthma, Tezepelumab is a human monoclonal antibody that inhibits thymic stromal lymphopoietin a cytokine generated from epithelial cells that is linked to the development of asthma more research is needed to determine the safety and effectiveness of Tezepelumab in treating individuals with severe uncontrolled asthma.

Keywords: Management, Tezepelumab, Monoclonal, Cytokine, lymphopoetin.

"Recently approved drug for Asthma management", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 12, page no.f115-f121, December-2023, Available :http://www.jetir.org/papers/JETIR2312513.pdf

"Recently approved drug for Asthma management", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 12, page no. ppf115-f121, December-2023, Available at : http://www.jetir.org/papers/JETIR2312513.pdf